Antiarrhythmic Drugs – Classification, Mechanisms of Action, and Toxicity Profiles for Cardiac Arrhythmia Management (2023) Unknown

Description

This text provides an overview of antiarrhythmic drugs, defining arrhythmias and detailing the Vaughan Williams classification system (Class I, II, III, IV). It includes diagrams of cellular action potential phases, a discussion of drug-induced adverse effects such as Torsades de pointes (associated with QT prolongation), and specific pharmacology and toxicity profiles for major broad-spectrum agents like Amiodarone.